Tortoise Investment Management, LLC Gh Research PLC Transaction History

Tortoise Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Aug 07, 2025	SELL	$5.34 - $11.09 $6,942 - $14,417	-1,300 Reduced 42.19%	1,781 $18,000
Q1 2024 May 09, 2024	SELL	$5.34 - $11.09 $6,942 - $14,417	-1,300 Reduced 42.19%	1,781 $18,000
Q4 2023 Aug 07, 2025	BUY	$5.26 - $11.04 $6,838 - $14,351	1,300 Added 72.99%	3,081 $17,000
Q3 2023 Aug 07, 2025	BUY	$9.8 - $14.15 $12,740 - $18,395	1,300 Added 72.99%	3,081 $30,000
Q3 2022 Nov 04, 2022	SELL	$10.15 - $16.15 $10,150 - $16,149	-1,000 Reduced 24.5%	3,081 $36,000

Q2 2022 Aug 03, 2022	BUY	$8.99 - $19.87 $36,688 - $81,089	4,081 New	4,081 $41,000

39.3M

12.2K

16.9K

Ticker GHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,020,800
Market Cap $728M
Description
GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tortoise Investment Management, LLC with notifications on news.